<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">8751</item><item key="factors"><item><item key="GSM1328942"><item key="GENOTYPE">wild type; Ptprd+/+p16-/-</item></item></item><item><item key="GSM1328942"><item key="GENOTYPE">wild type; Ptprd+/+p16-/-</item></item></item><item><item key="GSM1328944"><item key="GENOTYPE">HET; Ptprd+/-p16-/-</item></item></item><item><item key="GSM1328944"><item key="GENOTYPE">HET; Ptprd+/-p16-/-</item></item></item><item><item key="GSM1328948"><item key="GENOTYPE">KO; Ptprd-/-p16-/-</item></item></item><item><item key="GSM1328948"><item key="GENOTYPE">KO; Ptprd-/-p16-/-</item></item></item><item><item key="GSM1328948"><item key="GENOTYPE">KO; Ptprd-/-p16-/-</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">8</item><item key="summary_wrapped">PTPRD is a tumor suppressor of glioma that is frequently co-deleted with CDKN2A/p16. We show that Ptprd and p16 cooperate to promote...</item><item key="pubmed_id">24843164</item><item key="geo_gse_id">E-GEOD-55061</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">7</item><item key="tags"><item>glioma</item><item>nestin</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">expression-data-from-rcas-pdgfbnestin-tv-a-glioma</item><item key="geo_id_plat">E-GEOD-55061_A-AFFY-36</item><item key="name">Expression data from RCAS PDGFB/Nestin tv-A glioma cells within Ptprd+/+p16-/- (n=2), Ptprd+/-p16-/- (n=2), and Ptrpd-/-p16-/- (n=3) mice.</item><item key="created">Nov.24, 2014</item><item key="summary">PTPRD is a tumor suppressor of glioma that is frequently co-deleted with CDKN2A/p16. We show that Ptprd and p16 cooperate to promote gliomagenesis in the RCAS PDGFB / Nestin tv-A glioma mouse model. We found unique gene expression changes within tumor cells of Ptprd+/-p16-/- vs. Ptprd+/+p16-/- and Ptprd-/-p16-/- tumor cells. Neonatal mice were injected with RCAS PDGFB GFP. At symptoms, or at 12 weeks post injection, GFP+DAPI- tumor cells were sorted for RNA extraction and hybridization on Affymetrix microarrays.  The mouse strain used was a mixed background of C57/BL6 and FVB/N. Ptprd mice were from Uetani et al. 2000 and p16/Nestin-tvA mice were from Tchouganouva et al. 2007.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-55061</item><item key="species">mouse</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-55061/samples/</item></data></biogps>
